These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 22187097)

  • 1. Stress-induced hyperglycaemia and venous thromboembolism following total hip or total knee arthroplasty: analysis from the RECORD trials.
    Cohn DM; Hermanides J; DeVries JH; Kamphuisen PW; Kuhls S; Homering M; Hoekstra JB; Lensing AW; Büller HR
    Thromb Haemost; 2012 Feb; 107(2):225-31. PubMed ID: 22187097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.
    Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
    J Med Econ; 2011; 14(3):324-34. PubMed ID: 21506632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based epidemiology of postoperative venous thromboembolism in Taiwanese patients receiving hip or knee arthroplasty without pharmacological thromboprophylaxis.
    Wu PK; Chen CF; Chung LH; Liu CL; Chen WM
    Thromb Res; 2014 May; 133(5):719-24. PubMed ID: 24593913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism and bleeding after total knee and hip arthroplasty. Findings from the Spanish National Discharge Database.
    Guijarro R; Montes J; San Román C; Arcelus JI; Barillari G; Granero X; Monreal M
    Thromb Haemost; 2011 Apr; 105(4):610-5. PubMed ID: 21174008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of post-discharge venous thromboembolism on hospital quality comparisons following hip and knee arthroplasty.
    Kester BS; Merkow RP; Ju MH; Peabody TD; Bentrem DJ; Ko CY; Bilimoria KY
    J Bone Joint Surg Am; 2014 Sep; 96(17):1476-84. PubMed ID: 25187587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hip surgery sequentially induces stress hyperglycaemia and activates coagulation.
    Hermanides J; Huijgen R; Henny CP; Mohammad NH; Hoekstra JB; Levi MM; DeVries JH
    Neth J Med; 2009 Jun; 67(6):226-9. PubMed ID: 19749392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials.
    Friedman RJ; Dahl OE; Rosencher N; Caprini JA; Kurth AA; Francis CW; Clemens A; Hantel S; Schnee JM; Eriksson BI;
    Thromb Res; 2010 Sep; 126(3):175-82. PubMed ID: 20434759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty.
    Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
    J Med Econ; 2012; 15(4):644-53. PubMed ID: 22356512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgery.
    Baser O; Supina D; Sengupta N; Wang L; Kwong L
    Curr Med Res Opin; 2011 Feb; 27(2):423-9. PubMed ID: 21192759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.
    Kwong LM
    Am J Manag Care; 2011 Feb; 17(1 Suppl):S22-6. PubMed ID: 21517652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort study.
    Mismetti P; Samama CM; Rosencher N; Vielpeau C; Nguyen P; Deygas B; Presles E; Laporte S;
    Thromb Haemost; 2012 Jun; 107(6):1151-60. PubMed ID: 22476471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies.
    Turpie AG; Lassen MR; Eriksson BI; Gent M; Berkowitz SD; Misselwitz F; Bandel TJ; Homering M; Westermeier T; Kakkar AK
    Thromb Haemost; 2011 Mar; 105(3):444-53. PubMed ID: 21136019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
    Dager WE
    Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
    Eriksson BI; Dahl OE; Huo MH; Kurth AA; Hantel S; Hermansson K; Schnee JM; Friedman RJ;
    Thromb Haemost; 2011 Apr; 105(4):721-9. PubMed ID: 21225098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism following primary total hip arthroplasty.
    Hitos K; Fletcher JP
    Int Angiol; 2009 Jun; 28(3):215-21. PubMed ID: 19506541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism.
    Gangireddy C; Rectenwald JR; Upchurch GR; Wakefield TW; Khuri S; Henderson WG; Henke PK
    J Vasc Surg; 2007 Feb; 45(2):335-341; discussion 341-2. PubMed ID: 17264013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism prophylaxis after total knee or hip replacement: treatment pattern and outcomes.
    Penning-van Beest FJ; Overbeek JA; Meijer WM; Woodruff K; Jackson J; van der Vis H; van der Linden P; Herings RM
    Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):972-8. PubMed ID: 21748826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism rates in patients undergoing major hip and knee joint surgery at Waitemata District Health Board: a retrospective audit.
    Dixon J; Ahn E; Zhou L; Lim R; Simpson D; Merriman EG
    Intern Med J; 2015 Apr; 45(4):416-22. PubMed ID: 25644232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.